Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome P450 2F1 (CYP2F1) is a member of the cytochrome P450 superfamily of heme-containing monooxygenase enzymes, predominantly expressed in human lung tissue. CYP2F1 is involved in the oxidative metabolism of xenobiotics and endogenous toxins, catalyzing reactions such as monooxygenation and dehydrogenation of substrates like naphthalene, ethoxycoumarin, and 3-methylindole. These reactions contribute to drug metabolism, detoxification, and the biosynthesis of cholesterol and steroids. The enzyme is membrane-bound in the endoplasmic reticulum. Genetic variations in CYP2F1 may result in substantial interindividual differences in enzyme activity and susceptibility to chemically induced lung toxicity or carcinogenesis, although current evidence does not support a major direct role in lung cancer pathogenesis.
Oxidative metabolism (monooxygenation and dehydrogenation) of substrates including endogenous and xenobiotic compounds
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome P450 2F1 (CYP2F1).